| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $13.71M | $28.81M | – | – | – |
| R&D | $6.80M | $21.55M | $9.16M | $2.78M | $6.55M |
| SG&A | $6.91M | $7.26M | $6.73M | $8.64M | $8.75M |
| Operating Income | -$13.71M | -$28.81M | -$15.89M | -$19.63M | -$15.30M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$12.97M | -$27.59M | -$12.47M | -$13.97M | -$15.28M |
| EPS (basic) | -7.3500 | -3.5600 | -2.4600 | -5.4300 | -0.6600 |
| EPS (diluted) | -7.3500 | -3.5600 | -2.4600 | -5.4300 | -0.6600 |
| Shares (diluted) | $1.77M | $7.76M | $5.07M | $2.57M | $23.14M |